Physiol. Genomics Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Physiol. Genomics (February 19, 2008). doi:10.1152/physiolgenomics.00262.2007
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Table
Right arrow All Versions of this Article:
33/2/212    most recent
00262.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Gilibert, S.
Right arrow Articles by Bataillard, A. P
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gilibert, S.
Right arrow Articles by Bataillard, A. P
Submitted on November 7, 2007
Accepted on February 9, 2008

THE EFFECTS OF CHROMOSOME 17 ON FEATURES OF THE METABOLIC SYNDROME IN THE LYON HYPERTENSIVE (LH) RAT

Sophie Gilibert1, Anne E Kwitek2*, Norbert Hubner3, Michael Tschannen4, Howard J Jacob4, Jean Sassard5, and Alain P Bataillard6

1 Departement de Physiologie et Pharmacologie Clinique, Universite de Lyon, Lyon, France
2 Human Molecular and Genetics Center, Medical College of Wisconsin, Milwaukee, Wisconsin, United States; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, United States
3 Max Delbrueck Center for Molecular Medicine, Berlin-Buch, Germany
4 Human Molecular and Genetics Center, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
5 Departement de Physiologie et Pharmacologie Clinique, Faculte de Pharmacie, CNRS ESA 50148 Av Rockefeller, Lyon, France; Departement de Physiologie et Pharmacologie Clinique, Universite de Lyon, Lyon, France
6 Physiology and Clinical Pharmacology, Faculty of Pharmacy, Lyon, France; Departement de Physiologie et Pharmacologie Clinique, Universite de Lyon, Lyon, France

* To whom correspondence should be addressed. E-mail: anne-kwitek{at}uiowa.edu.

The metabolic syndrome (involving obesity, hypertension, dyslipidemia, insulin resistance, and a proinflammatory/prethrombotic state), is a major risk factor for cardiovascular disease. Its incidence continues to rise, in part because of the epidemic increase in obesity. The Lyon Hypertensive (LH) rat is a model for hypertension and several other features for the metabolic syndrome, having high body weight, plasma cholesterol and triglycerides, increased insulin/glucose ratio, and salt-sensitive hypertension. Previous genetic studies in LH/Mav and a normotensive control (LN/Mav) identified Quantitative Trait Loci (QTLs) on rat chromosome (RNO) 17 for multiple features of the metabolic syndrome. To further evaluate the role of RNO17 in the LH, we generated a consomic strain (LH-17BN) by substituting LH RNO17 with that of the sequenced Brown Norway (BN/NHsdMcwi) rat. Male LH and BN, and LH-17BN rats were characterized for blood pressure, metabolic and morphological parameters. Similar to the protective effect of LN alleles, the LH-17BN also shows decreased body weight, triglycerides, and blood pressure; however there was no significant difference in cholesterol or insulin/glucose ratios. Therefore, the substitution of the LH chromosome 17 is sufficient to recapitulate some, but not all, of the traits previously mapped to this chromosome. This could be due to the lack of a susceptible LH genome background or due to the introgression of chromosome 17 from another strain. Regardless, this study provides a single-chromosome genetic model for further dissection of blood pressure, morphological, and metabolic traits on this chromosome.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.